2-methylpentane has been researched along with Psoriasis in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Aydt, E; Bock, D; Dam, TN; Friedrich, M; Kang, S; Ludwig, N; Philipp, S; Sabat, R; Schroeter-Maas, S; Sterry, W; Wolff, G; Wolk, K; Zahlten, R | 1 |
1 trial(s) available for 2-methylpentane and Psoriasis
Article | Year |
---|---|
Pan-selectin antagonism improves psoriasis manifestation in mice and man.
Topics: Adult; Animals; Anti-Inflammatory Agents; Cell Adhesion; Cell Line; Cell Proliferation; Disease Models, Animal; Endothelium, Vascular; Epidermis; Female; Hexanes; HL-60 Cells; Humans; Jurkat Cells; Leukocytes; Male; Mannose; Mice; Mice, SCID; Middle Aged; P-Selectin; Pilot Projects; Psoriasis; T-Lymphocytes | 2006 |